{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-23-000088","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2023-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.414782+00:00","generated_at":"2026-06-19T22:51:04.678856+00:00","sec_items":["5.02","3.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BioSig CFO Steve Chaussy retires; Steve Buhaly appointed as CFO","bullets":["Chaussy's employment terminates on or before April 28, 2023; gets up to 250k restricted shares (two tranches) contingent on stockholder approval of 2023 LTIP.","Buhaly, former Qorvo CFO, appointed effective Feb 6, 2023; annual base salary $100k; eligible for options to acquire 250k shares vesting quarterly over 12 months.","January PIPE: 1,665,384 shares at $0.7806 and warrants for $1.3M; Laidlaw warrant for 124,904 shares at $0.7181 issued.","Buhaly brings 15 years of public company CFO experience, co-led $2B+ M&A, helped raise $1B in debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-23-000088","json":"https://secwatch.observer/filing/0001185185-23-000088.json","markdown":"https://secwatch.observer/filing/0001185185-23-000088.md","text":"https://secwatch.observer/filing/0001185185-23-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000088/0001185185-23-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000088/biosig20230202_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T22:51:04.678856+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0fe13195de","claim":"Steve Chaussy was terminated as Chief Financial Officer at Streamex Corp..","evidence_excerpt":"On February 2, 2023, the BioSig Technologies, Inc. (the “ Company ”) entered into a General Release and Severance Agreement (the “ Release Agreement ”) with Steve Chaussy, Chief Financial Officer of the Company, pursuant to which Mr. Chaussy’s employment with the Company will terminate upon the earlier of April 28, 2023, or the date of an earlier termination","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000088/0001185185-23-000088-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"8aebdc95c2","claim":"Steve Buhaly was appointed as Chief Financial Officer at Streamex Corp..","evidence_excerpt":"On February 2, 2023, the Board appointed Mr. Steve Buhaly as the Chief Financial Officer of the Company, whose employment will commence on February 6, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000088/0001185185-23-000088-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}